11-Beta-hydroxyandrostenedione-4-Androsten-11β-ol-3-17-dione-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
11-Beta-hydroxyandrostenedione-4-Androsten-11β-ol-3-17-dione-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
11-Beta-hydroxyandrostenedione-4-Androsten-11β-ol-3-17-dione-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemE11-Beta-hydroxyandrostenedioneCat. No.: HY-114464CAS No.: 382-44-5Synonyms: 4-Androsten-11-ol-3,17-dione分式: CHO分量: 302.41作靶點(diǎn): Endogenous Metabolite作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6

2、 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 250 mg/mL (826.69 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 3.3068 mL 16.5338 mL 33.0677 mL5 mM 0.6614 mL 3.3068 mL 6.6135 mL10 mM 0.3307 mL 1.6534 mL 3.3068 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 11-Beta-

3、hydroxyandrostenedione (4-Androsten-11-ol-3,17-dione)種主存在于腎上腺的類醇 (11-羥化酶存在于腎上腺組織,但在巢組織中不存在)。11-Beta-hydroxyandrostenedione種 11-羥基類醇脫氫酶 (11HSD) 同酶抑制劑。隨4-androstenedione 的增加,測(cè)量漿 11-Beta-hydroxyandrostenedione 可以區(qū)分雄激素癥的腎上腺或巢起。IC50 & Target Human Endogenous Metabolite1/2 Master of Small Molecules 您邊的抑制劑

4、師www.MedChemE體外研究 In order to establish that this conversion is catalysed by the lyase activity of CYP17A1, 21-deoxycortisol(21dF) and 21-deoxycortisone (21dE) is assayed within the LNCaP cell line. Upon the transfection ofCYP17A1, 11-Beta-hydroxyandrostenedione (11OHA4)-pathway metabolites increase

5、, 21dF and 21dE are infact metabolised to 11-Beta-hydroxyandrostenedione and 11-ketoprogesterone (11KP4) by CYP17A1,respectively 2.體內(nèi)研究 The plasma concentration of 11-Beta-hydroxyandrostenedione (11beta-hydroxy-4-androstene-3,17-dione) isvery high in 21-hydroxylase deficiency, Cushings syndrome, and

6、 hyperandrogenism of adrenal origin, andvery low in congenital 11-hydroxylase deficiency and adrenal insufficiency. Thus, when plasma 4-androstenedione is elevated, it is useful to measure the plasma 11-Beta-hydroxyandrostenedione level inorder to determine the adrenal or ovarian origin of the hyper

7、androgenism 1.REFERENCES1. Ibrahim F, et al. Plasma 11beta-hydroxy-4-androstene-3,17-dione: comparison of a time-resolved fluoroimmunoassay using abiotinylated tracer with a radioimmunoassay using a tritiated tracer. J Steroid Biochem Mol Biol. 2003 Apr;84(5):563-8.2. Rachelle Gent, et al. 11-Hydroxyprogesterone, a potent 11-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5-reductase and cytochrome P450 17hydroxylase/17,20-lyase to produce C11-derivatives of 21-deoxycortisolMcePdfHeightCaution: Product has not been fully validated for medical applications.For

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論